FDAsafety guidance83% confidence
Rare Disease Drug Approvals
Source: FDA
Why This Matters
Why this matters: illustrates how regulators handled a comparable safety guidance decision relevant to pilonidal sinus disease treatments.
Regulatory Analysis
This page describes recent rare disease drug approvals that received CDER or FDA communication. This is not an exhaustive list of all rare disease drug approvals.
Supporting Context
- Therapeutic area
- Surgery · Pilonidal Sinus Disease
- Sub-indication
- General
Related signal: Trial Compares Laser Ablation vs Crystallized Phenol for Pilonidal Sinus Disease